Monitor for any reverse stock split announcement or capital raise as the company attempts to regain compliance before March 24, 2027. The dual deficiency (bid price + MVLS) makes cure more challenging than a single deficiency — a reverse split alone may not solve the MVLS issue if the market cap remains depressed.
Price Chart
Executive Summary
Dyadic International received two Nasdaq deficiency notices on September 25, 2026: one for failing to maintain the minimum $1.00 bid price (Rule 5550(a)(2)) and another for failing to maintain the minimum $35 million Market Value of Listed Securities (Rule 5550(b)(2)), each for 30 consecutive business days. The company has 180 calendar days (until March 24, 2027) to regain compliance on both fronts, with a potential second 180-day cure period for the bid price deficiency if eligible. Failure to cure could lead to delisting, which would severely impact liquidity and institutional ownership.
Key Facts
- Received Nasdaq deficiency notice on September 25, 2026 for minimum bid price < $1.00 per share for 30 consecutive business days
- Received separate Nasdaq deficiency notice for Market Value of Listed Securities (MVLS) below $35 million for 30 consecutive business days
- Compliance deadline for both deficiencies is March 24, 2027 (180 calendar days)
- Company may be eligible for an additional 180-day cure period for bid price if it meets other initial listing standards
- Company plans to evaluate options including a potential reverse stock split to regain compliance
Financial Impact
Dual Nasdaq deficiency notices create material delisting risk; delisting would severely reduce liquidity and institutional ownership, likely causing significant share price depreciation
Risk Factors
- Failure to regain compliance by March 24, 2027 could lead to Nasdaq delisting
- Reverse stock split, if pursued, may not cure the MVLS deficiency and could further pressure the stock
- Appeal process exists but success is not assured
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-044398 |
| Document: 0001493152-26-044398-index-headers.html | 0001493152-26-044398 |
| Document: 0001493152-26-044398-index.html | 0001493152-26-044398 |
| Document: 0001493152-26-044398.txt | 0001493152-26-044398 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 11d ago | SC 13G | $0.4194 | awaiting T+20 | — | $0.4200 (+0.14%) |
Sep 25, 2026 4w ago | 8-K | $0.4650 $0.4160 | ▲ +10.54% | ▲ +10.51% | $0.4200 (+9.68%) |
Sep 21, 2026 5w ago | EFFECT | $0.4010 $0.3809 | ▲ +5.01% | ▲ +4.10% | $0.4200 (−4.74%) |
Aug 14, 2026 10w ago | 8-K | $0.7751 $0.4244 | ▲ +45.25% | ▲ +43.25% | $0.4200 (+45.81%) |
Aug 12, 2026 10w ago | 8-K | $0.8800 $0.4898 | ▲ +44.34% | ▲ +42.44% | $0.4200 (+52.27%) |
Aug 12, 2026 10w ago | Press Release | $0.8800 $0.4898 | ▲ +44.34% | ▲ +42.44% | $0.4200 (+52.27%) |
Jul 24, 2026 13w ago | 8-K | $1.19 $0.6900 | ▼ −42.02% | ▼ −45.64% | $0.4200 (−64.71%) |
Jun 18, 2026 18w ago | DEFA14A | $0.7820 $1.19 | ▼ −52.17% | ▼ −51.64% | $0.4200 (+46.29%) |
May 28, 2026 21w ago | 8-K | $0.7100 $0.8010 | ▲ +12.82% | ▲ +15.96% | $0.4200 (−40.85%) |
Mar 25, 2026 30w ago | Press Release | $0.7000 $0.8600 | ▲ +22.86% | ▲ +12.19% | $0.4200 (−40.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers